Category: Blog

The One Thing Every Vc Must Learn From Softbank’s Masa

The wild swings in SoftBank and Masayoshi Son’s fortunes are back in spotlight in the wake of activist investor Elliott Management’s move to force SoftBank a fresh share buyback. Elliott has built a stake of USD2 billion in SoftBank.   In 2020, when SoftBank Vision Fund was in doldrums and the pandemic struck, Elliott, which […]

Read More

Why Mankind, Dr Reddy’s And Pe Firms Are So Interested In Low-profile Bsv

“They gave us a tough fight.” Pithy words from a senior executive at a European drug maker with a portfolio of women’s health products sums up the point. His reference is to BSV, formerly Bharat Serums and Vaccines, which for a large part of its four decades of existence, quietly grew selling specialised drugs, mostly […]

Read More